XML 45 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Balance Sheet Components (Tables)
 3 Months Ended
Mar. 31, 2022
Balance Sheet Related Disclosures [Abstract]  
Schedule of Intangible Assets Intangible assets consisted of the following (in thousands of dollars):
 March 31, 2022December 31, 2021Weighted Average Amortization Period (Years)
 Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Percepta product technology$16,000 $(7,467)$8,533 $16,000 $(7,200)$8,800 15
Prosigna product technology4,120 (641)3,479 4,120 (572)3,548 15
Prosigna customer relationships2,430 (1,134)1,296 2,430 (1,013)1,417 5
nCounter Dx license46,880 (7,292)39,588 46,880 (6,511)40,369 15
LymphMark product technology990 (330)660 990 (295)695 7
Decipher product technology90,000 (9,484)80,516 90,000 (7,234)82,766 10
Decipher trade names4,000 (843)3,157 4,000 (643)3,357 5
HalioDx developed technology44,781 (2,961)41,820 45,640 (1,877)43,763 10
HalioDx customer relationships4,778 (556)4,222 4,870 (352)4,518 6
HalioDx customer backlog6,778 (1,121)5,657 6,908 (710)6,198 4
Total finite-lived intangibles220,757 (31,829)188,928 221,838 (26,407)195,431 10.9
In-process research and development7,300 — 7,300 7,300 — 7,300 
Total intangible assets$228,057 $(31,829)$196,228 $229,138 $(26,407)$202,731 
Schedule of Future Aggregate Amortization Expense The estimated future aggregate amortization expense as of March 31, 2022 is as follows (in thousands of dollars):
Year Ending December 31,Amounts
2022 remainder of year$16,431 
202321,908 
202421,868 
202520,725 
202618,844 
Thereafter89,152 
Total$188,928 
Schedule of Accrued Liabilities
Accrued liabilities consisted of the following (in thousands of dollars):
 
 March 31, 2022December 31, 2021
Accrued compensation expenses$29,525 $30,792 
Accrued other9,018 8,683 
Total accrued liabilities$38,543 $39,475